Thyrocare Technologies Ltd operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Thyrocare Technologies Ltd with three other
pharmaceutical manufacturers in Asia:
Malaysian Genomics Resource Centre Berhad
sales of 26.16 million Malaysian Ringgits [US$6.28 million]
Ina Research Incorporation
(2.43 billion Japanese Yen [US$21.52 million]
Medical & Biological Laboratories Company Limited
based in Japan
(7.07 billion Japanese Yen [US$62.73 million]
of which 99%
was Reagent business).
During the year ended March of 2018, sales at
Thyrocare Technologies Ltd were 3.56 billion Indian Rupees (US$50.28 million).
increase of 16.1%
versus 2017, when the company's sales were 3.07 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Thyrocare Technologies Ltd
(and since 2013, sales have increased a total of 165%).